3Williams SG,Wight DJ,Tan LB.Management of cardiogenic shock compicating acute myodardial infarction:towards evidence base medical practice[J].Heart,2000,83(2):621-626.
4Kontra JM.Evidence-based management of severe sepsis and septic shock[J].J Lancaster Hosp,2006,1(2):39-46.
5Dellinger RP,Levy MM,Carlet JM,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock[J].Intensive Care Med,2008,34(1):17-60.
6Bertrand ME,McFadden E.Cardiogenic shock:is there light at the end of the tunnel[J] ? J Am Coll Cardiol,2003,42(8):1387-1388.
7Cantor WJ,Brunet F,Ziegler CP,et al.Immediate angioplasty after thrombolysis:a systematic review[J].CMAJ,2005,173(12):1473-1481.
10Konrad D,Oldner A,Rossi P,et al.Differentiated and dose related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock[J].Crit Care Med,2004,32(5):1192-1199.